Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence,” with a link to updates and FAQs. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:26:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:52.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the usual study content. This change replaces the study details with an error screen, indicating restricted access to the record.
    Difference
    20%
    Check dated 2026-09-23T00:40:46.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, representing a new version of the study page. This is a metadata/version control change and does not reflect changes to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-15T23:41:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5; this marks a minor update to the page's documentation/UI rather than a change to trial details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-01T19:58:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now includes a funding note indicating 2019 U.S. NIH grant/contract support for the study. This adds funding context to the record.
    Difference
    0.0%
    Check dated 2026-08-25T21:41:33.000Z thumbnail image

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.